Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
about
Oral converting enzyme inhibitor in malignant hypertension.Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.The effect of enalapril on the renal response to tilting in humans.Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patientsContrast-induced nephropathy in interventional cardiologyAngiotensin converting enzyme inhibition: a new therapeutic modality.Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and arginine vasopressin.Side effects and metabolic effects of converting-enzyme inhibitors.Effect of captopril on renal function in patients with congestive heart failure.Safety and efficacy of chronic therapy with captopril in hypertensive patients: an update.Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521The causal role of salt depletion in acute renal failure due to captopril in hypertensive patients with a single functioning kidney and renal artery stenosis.Effects of repeated doses of enalapril on renal function in man.Effects of acute and chronic cilazapril treatment in spontaneously hypertensive rats.Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions--parallels and contrasts.Implications of antihypertensive therapy on sodium balance and sodium and water retention.Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide.Effect of salt balance on the renal and hemodynamic actions of benazepril in normal men.
P2860
Q33476828-4493B368-96F2-4CF2-92B1-C6BF6AAB8CF9Q34070505-B5B084B8-C65B-480C-A114-A062E73B6CCEQ34397210-1ADD7033-7A7F-4E2C-B7D7-FF340DE3B9B0Q34513285-AE51E7A9-E397-4BDA-AF76-69F2572CEF61Q35193141-94D712F4-67E7-4116-A9AF-F8ACD35D020CQ35651176-15DB34F1-9659-468C-8338-7363E6229AA0Q36990146-FE715A23-781D-4597-BB94-97A3BB7FE059Q39510464-F73A8083-1EEF-4D5D-AE77-987F8DE7E779Q41322685-E34E2C40-ABD7-4233-8948-D7687D1E51DEQ41466880-CAF8A4F4-757F-4027-A5C4-E122367EB4DFQ41875348-B8564E83-970C-4912-9291-47C1A8D60419Q42217442-E3867254-36AC-403C-B7A9-35A807D6B05DQ42531254-F0ED0546-2185-4A36-AB04-B59BEFCCC34EQ43222299-493B5A48-08F0-4E5D-8573-F0390971CEDCQ43228807-20EF3F57-45C9-4B4F-862B-F27CA8E8454DQ46519171-61A12D37-1689-472C-8DB5-8407316B2186Q54157986-5C787201-386A-46AC-9B4A-65F6B1E35F36Q54343503-8C516011-2E33-4D46-83D9-6C6D3A036B27
P2860
Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Increased glomerular filtratio ...... ion in essential hypertension.
@en
type
label
Increased glomerular filtratio ...... ion in essential hypertension.
@en
prefLabel
Increased glomerular filtratio ...... ion in essential hypertension.
@en
P2093
P1476
Increased glomerular filtratio ...... ion in essential hypertension.
@en
P2093
Hollenberg NK
Williams GH
P356
10.1056/NEJM197907053010103
P407
P577
1979-07-01T00:00:00Z